Oncolytic Adenovirus Armed with Multiple Immune Stimulatory Transgenes in Combination with PD-L1-Targeted Radioimmunotherapy Exert Synergistic Antitumor Effect Against Pancreatic Cancer

被引:0
|
作者
Yun, Chae-Ok [1 ,2 ]
Yoon, A-Rum [2 ]
Lee, Jeongwon [2 ]
Seo, Jea Hyun [2 ]
机构
[1] Gene Med, Seoul, South Korea
[2] Hanyang Univ, Seoul, South Korea
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
1668
引用
收藏
页码:781 / 781
页数:1
相关论文
共 13 条
  • [11] Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy
    Lipeng Zhu
    Junnan Li
    Ziang Guo
    Hang Fai Kwok
    Qi Zhao
    Journal of Nanobiotechnology, 20
  • [12] Combination of mesothelin-targeted immune-activating fusion protein and anti-PD-L1 augments antitumor immunity and prolongs survival in murine model of ovarian cancer
    Zeng, Yang
    Li, Binghao
    Liu, Qiuyan
    Reeves, Patrick
    Sluder, Ann
    Gelfand, Jeffrey
    Brauns, Timothy
    Poznansky, Mark
    Chen, Huabiao
    CANCER RESEARCH, 2017, 77
  • [13] Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers
    Kaneko, Kensuke
    Acharya, Chaitanya R.
    Nagata, Hiroshi
    Yang, Xiao
    Hartman, Zachary Conrad
    Hobeika, Amy
    Hughes, Philip F.
    Haystead, Timothy A. J.
    Morse, Michael A.
    Lyerly, Herbert Kim
    Osada, Takuya
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)